Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma]
Postoperative Pain
Medical University of WarsawPhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 81/ 100
Competitive context
23 Active assets in the Postoperative Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ROPIVACAINE Tianjin Medical University General Hospital | Phase 4 | BBB |
LIDOCAINE Instituto Mexicano del Seguro Social | Phase 4 | BBB |
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Tanta University | Phase 4 | BBB |
NEPENTHE IVO JURISIC | Phase 4 | BBB |
FENTANYL IVO JURISIC | Phase 4 | BB |
View all 39 →
Same molecule, other indications
Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma] is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →